← Back to Search
Efficient delivery of ocular therapeutics with improved efficacy, enhanced bioavailability,
and acceptable patient compliance presents unique challenges. This can be attributed to the presence of
protective mechanisms, physicobiological barriers, and structural obstacles in the eye. Nanotherapeutic
interventions have been explored extensively over the past few years to overcome these limitations.
The present review focusses on the nanoformulations developed for the diagnosis and treatment
of various ocular diseases besides providing an in-depth insight into the patents reported for the
same.
Twitter
Facebook
LinkedIn
Email